Featured blog post: E-cigarettes affect lung biology, even in those who’ve never smoked
Research into the potential health effects of e-cigarettes has so far focused on in vitro studies or on users who are ex-cigarette smokers. But how do e-cigarettes affect people who have never smoked before? A new study published in Respiratory Research finds that in a small sample of volunteers, smoking e-cigarettes lead to clear changes in lung biology, suggesting further research is needed before we label e-cigarettes as harmless.
Aims and scope
Respiratory Research publishes high-quality clinical and basic research, review and commentary articles on all aspects of respiratory medicine and related diseases.
As the leading fully open access journal in the field, Respiratory Research provides an essential resource for pulmonologists, allergists, immunologists and other physicians, researchers, healthcare workers and medical students with worldwide dissemination of articles resulting in high visibility and generating international discussion.
Robert Bals, Saarland University, Germany
Francesco Blasi, University of Milan, Italy
Arnaud Bourdin, University of Montpellier, France
Mario Cazzola, University of Rome Tor Vergata, Italy
Suzanne Cloonan, Weill Cornell Medicine, USA
Taylor Cohen, MedImmune, USA
Bruno Crestani, Bichat Hospital, France
Jeanine D'Armiento, Columbia University College of Physicians and Surgeons, USA
Olivier Danhaive, University of California San Francisco, USA
Massimo Di Maio, University of Turin, Italy
Louise Donnelly, Imperial College London, UK
Hiromasa Inoue, Kagoshima University, Japan
Victor Laubach, University of Virginia, USA
Stylianos Orfanos, National and Kapodistrian University of Athens, Greece
Stephen Peters, Wake Forest University Health Sciences, USA
YS Prakash, Mayo Clinic, USA
Oliver Schildgen, Hospital of the Private University Witten/Herdecke, Germany
Dale D Tang, Albany Medical College, USA
Kelan Tantisira, Brigham and Women's Hospital, USA
Johan Verbraecken, Antwerp University Hospital, Belgium
Featured article: The genetics of smoking in individuals with chronic obstructive pulmonary disease
Smoking is the principal modifiable environmental risk factor for chronic obstructive pulmonary disease (COPD). Most of the genetic studies of smoking have relied on self-reported smoking status which is vulnerable to reporting and recall bias. This study demonstrates that using objective measures of smoking such as eCO and/or salivary cotinine can more precisely capture the genetic contribution to multiple aspects of smoking behaviour.
Professor at the Department of Internal Medicine, and Chairman of the Krefting Research Centre at the University of Gothenburg.
Submit your review
Sign up to receive article alerts
Respiratory Research is published continuously online-only and so we encourage you to sign up to receive free email alerts to keep up to date with all of the latest research by registering here.
2017 Journal Metrics
44.5 days from submission to first decision
120.7 days from submission to acceptance
13.4 days from acceptance to publication
2151 Altmetric Mentions